Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with a maximum dose of 50 units of insulin degludec in Japanese individuals with type 2 diabetes in a phase 3, double‐blind, randomized trial-Reference-Cited by-同舟云学术

Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with a maximum dose of 50 units of insulin degludec in Japanese individuals with type 2 diabetes in a phase 3, double‐blind, randomized trial

Published:2019-09-17 Issue:12 Volume:21 Page:2694-2703
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Watada Hirotaka¹^ORCID,Kaneko Shizuka²,Komatsu Mitsuhisa³,Agner Bue Ross⁴,Nishida Tomoyuki⁵,Ranthe Mattis⁴,Nakamura Jiro⁶

Affiliation:

1. Department of Metabolism and EndocrinologyJuntendo University Graduate School of Medicine Tokyo Japan

2. Division of Diabetes/Endocrinology/Lifestyle‐related DiseaseTakatsuki Red Cross Hospital Takatsuki Japan

3. Department of Diabetes, Endocrinology and Metabolism, Division of Internal MedicineShinshu University School of Medicine Matsumoto Japan

4. Novo Nordisk A/S Søborg Denmark

5. Novo Nordisk Pharma Ltd Tokyo Japan

6. Division of Diabetes, Department of Internal MedicineAichi Medical University School of Medicine Nagakute Japan

Funder

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13859

Reference29 articles.

1. Federation ID. IDF Atlas 8th Edition: Japan country report.http://reports.instantatlas.com/report/view/846e76122b5f476fa6ef09471965aedd/JPN. Accessed March 4 2019.

2. Trends in the epidemiology of patients with diabetes in Japan;Morimoto A;Japan Med Assoc J.,2010

3. Type 1 diabetes in Japan

4. Epidemiology of diabetes;Forouhi NG;Medicine (Abingdon).,2014

5. Diabetes in Asia

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The change in Fibrosis‐4 index in Japanese patients with type 2 diabetes treated by a fixed‐ratio combination therapy of insulin degludec and liraglutide: A retrospective observational study;Hepatology Research;2024-01-09

2. Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes;Diabetology International;2024-01-08

3. IDegLira for type 2 diabetes: a systematic review and meta-analysis;Endocrine;2023-09-28

4. Retrospective Study of IDegLira, a New Fixed-Ratio Combination, in Japanese Patients With Type 2 Diabetes Mellitus: Analysis of Background Factors Affecting Effectiveness After 6 Months of Treatment;Journal of Clinical Medicine Research;2023-09

5. Distinct hypoglycemic effect of different formulations of a fixed ratio of basal insulin plus glucagon-like peptide-1 receptor agonist in a patient with pancreatic diabetes;Diabetology International;2023-04-10